EP MedSystems
This article was originally published in The Gray Sheet
Executive Summary
Cardiac electrophysiology products company's $3.25 mil. equity financing agreement is led by Cardiac Capital, which is 50% owned by EP MedSystems Chairman and CEO David Jenkins. Cardiac Capital will receive 1.5 mil. shares of common stock and warrants for 750,000 additional shares exercisable at $4, out of a total 1.63 mil. shares and 812,500 warrants. Jenkins has agreed not to sell any previously owned shares for one year after the deal closes. Proceeds will be used to expand the Mt. Arlington, New Jersey firm's sales, marketing and manufacturing capabilities. FDA has granted EP MedSystems' ALERT catheter expedited PMA review for treatment of atrial fibrillation
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.